CONGRESS -
Senators Sanders and Marshall Release Bipartisan Primary Care and Health Workforce Act. Released on September 14, the legislation would reauthorize funding for a number of healthcare workforce programs that are...more
9/20/2023
/ Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Investigations & Hearings ,
Coronavirus/COVID-19 ,
DEA ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
GAO ,
Health Care Providers ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Medicare ,
Pharmaceutical Industry ,
Proposed Legislation ,
U.S. House
CONGRESS -
House Republicans Release Healthcare Package. On September 6, House Republicans unveiled the Lower Costs, More Transparency Act, a draft package of healthcare transparency provisions, pharmacy benefit manager...more
9/11/2023
/ Artificial Intelligence ,
Centers for Medicare & Medicaid Services (CMS) ,
CMMI ,
Congressional Committees ,
Department of Health and Human Services (HHS) ,
Department of Labor (DOL) ,
Disability Discrimination ,
Drug Pricing ,
Fair Labor Standards Act (FLSA) ,
Healthcare ,
Healthcare Reform ,
HELP ,
Legislative Agendas ,
Long Term Care Facilities ,
Long-Term Care ,
New Legislation ,
Over-Time ,
Pharmaceutical Industry ,
Prescription Drugs ,
Proposed Legislation ,
Proposed Rules ,
Request For Information ,
Rural Health Care Program ,
Transparency
The price of prescription drugs has brought scrutiny to the entire drug supply chain. Congress and other policymakers continue to seek opportunities to lower costs for patients and the federal government.
Pharmacy benefit...more
9/6/2023
/ Drug Pricing ,
MCOs ,
Medicare ,
Medicare Advantage ,
Medicare Part D ,
Pharmaceutical Industry ,
Pharmacies ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drug Coverage ,
Prescription Drugs ,
Supply Chain
The House and Senate were both in session this week, with healthcare activity continuing at the committee level. The House Energy and Commerce Committee held hearings on the Pandemic and All Hazards Preparedness Act (PAHPA)...more
6/16/2023
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Debt ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Healthcare ,
HELP ,
Hospitals ,
Legislative Agendas ,
Medicaid ,
Medicare ,
New Legislation ,
Pharmaceutical Industry ,
Proposed Legislation ,
Regulatory Agenda ,
Telehealth ,
Transgender
The House and Senate were both in session this week, with significant healthcare activity at the committee level. The House Ways & Means Committee met to discuss healthcare price transparency, and the Ways & Means Health...more
5/19/2023
/ Abortion ,
Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Coronavirus/COVID-19 ,
Data Privacy ,
Data Protection ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
GAO ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Medicaid ,
Medicare Advantage ,
New Legislation ,
New Regulations ,
Non-Compete Agreements ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Price Transparency ,
Proposed Legislation ,
Proposed Regulation ,
Regulatory Agenda ,
Ways and Means Committee
The House and Senate were both in session this week. The House Ways & Means Health Subcommittee met to discuss policies inhibiting innovation and patient access, and the House Energy & Commerce Health Subcommittee held a...more
5/12/2023
/ Congressional Investigations & Hearings ,
Coronavirus/COVID-19 ,
DEA ,
Deadlines ,
GAO ,
Healthcare ,
HELP ,
Legislative Agendas ,
Patient Access ,
Pharmaceutical Industry ,
Prescription Drugs ,
Public Health Emergency
The House held a district work week while the Senate was in session, with plenty of healthcare action at the committee level. The Senate Finance Committee held a hearing on barriers to mental health care. The Senate Health,...more
5/8/2023
/ Biden Administration ,
Children's Health Insurance Program (CHIP) ,
Coronavirus/COVID-19 ,
DEA ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
HELP ,
MACPAC ,
Mental Health ,
Pharmaceutical Industry ,
Public Health Emergency
Congress was in session, and it was a busy healthcare week at the committee level, with six hearings focused specifically on health issues. On the House floor, Republicans passed the Limit, Save, Grow Act—a bill that raises...more
5/2/2023
/ Abortion ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Congressional Investigations & Hearings ,
Coronavirus/COVID-19 ,
DACA ,
Department of Health and Human Services (HHS) ,
Enforcement Actions ,
Federal Funding ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
HELP ,
Hospitals ,
Medicaid ,
New Legislation ,
Pharmaceutical Industry ,
Prescription Drugs ,
Price Transparency ,
Proposed Legislation ,
Proposed Rules ,
Right of Access